Subscribe
shutterstock_473806648_amy_kerkemeyer
Amy Kerkemeyer / Shutterstock.com
18 November 2021AmericasAlex Baldwin

Judge approves Pfizer’s $345m EpiPen settlement

EpiPen buyers have secured final approval of a $345 million settlement with Pfizer in a consumer antitrust suit.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
EpiPen patent revoked in Europe
2 May 2018   The European Patent Office has revoked a patent covering Mylan’s EpiPen injector after finding that patent amendments contravened the European Patent Convention (EPC).
Americas
FDA grants Teva approval for first EpiPen generic
17 August 2018   The US Food and Drug Administration yesterday granted Teva approval for the first generic version of EpiPen, an autoinjector pen used for the emergency treatment of allergic reactions.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Europe
EpiPen patent revoked in Europe
2 May 2018   The European Patent Office has revoked a patent covering Mylan’s EpiPen injector after finding that patent amendments contravened the European Patent Convention (EPC).
Americas
FDA grants Teva approval for first EpiPen generic
17 August 2018   The US Food and Drug Administration yesterday granted Teva approval for the first generic version of EpiPen, an autoinjector pen used for the emergency treatment of allergic reactions.

More on this story

Europe
EpiPen patent revoked in Europe
2 May 2018   The European Patent Office has revoked a patent covering Mylan’s EpiPen injector after finding that patent amendments contravened the European Patent Convention (EPC).
Americas
FDA grants Teva approval for first EpiPen generic
17 August 2018   The US Food and Drug Administration yesterday granted Teva approval for the first generic version of EpiPen, an autoinjector pen used for the emergency treatment of allergic reactions.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility